WuXi Biologics (Cayman), Inc. (WXIBF)
6.77
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
WuXi Biologics Max Drawdown (5Y) : 93.22% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 93.22% |
| August 31, 2026 | 93.22% |
| July 31, 2026 | 93.22% |
| June 30, 2026 | 93.22% |
| May 31, 2026 | 93.22% |
| April 30, 2026 | 93.22% |
| March 31, 2026 | 93.22% |
| February 28, 2026 | 93.22% |
| January 31, 2026 | 93.22% |
| December 31, 2025 | 93.22% |
| November 30, 2025 | 93.22% |
| October 31, 2025 | 93.22% |
| September 30, 2025 | 93.22% |
| August 31, 2025 | 93.22% |
| July 31, 2025 | 93.22% |
| June 30, 2025 | 93.22% |
| May 31, 2025 | 93.22% |
| April 30, 2025 | 93.22% |
| March 31, 2025 | 93.22% |
| February 28, 2025 | 93.22% |
| January 31, 2025 | 93.22% |
| December 31, 2024 | 93.22% |
| November 30, 2024 | 93.22% |
| October 31, 2024 | 93.22% |
| September 30, 2024 | 93.22% |
| Date | Value |
|---|---|
| August 31, 2024 | 93.22% |
| July 31, 2024 | 92.90% |
| June 30, 2024 | 92.80% |
| May 31, 2024 | 92.38% |
| April 30, 2024 | 91.41% |
| March 31, 2024 | 90.94% |
| February 29, 2024 | 88.52% |
| January 31, 2024 | 86.95% |
| December 31, 2023 | 82.41% |
| November 30, 2023 | 75.63% |
| October 31, 2023 | 75.63% |
| September 30, 2023 | 75.63% |
| August 31, 2023 | 75.63% |
| July 31, 2023 | 75.63% |
| June 30, 2023 | 75.63% |
| May 31, 2023 | 75.63% |
| April 30, 2023 | 75.63% |
| March 31, 2023 | 75.63% |
| February 28, 2023 | 75.63% |
| January 31, 2023 | 75.63% |
| December 31, 2022 | 75.63% |
| November 30, 2022 | 75.63% |
| October 31, 2022 | 75.63% |
| September 30, 2022 | 69.93% |
| August 31, 2022 | 69.93% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Repligen Corp. | 68.27% |
| Sinovac Biotech Ltd. | 25.46% |
| Bio-Techne Corp. | 67.22% |
| CASI Pharmaceuticals, Inc. | 99.54% |
| BioLife Solutions, Inc. | 85.14% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.20 |
| Beta (5Y) | 0.0400 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 70.69% |
| Historical Sharpe Ratio (5Y) | -0.2801 |
| Historical Sortino (5Y) | -0.5564 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.34% |